Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers

J Glob Health. 2020 Dec;10(2):020378. doi: 10.7189/jogh.10.020378.

Authors

Md Sakirul Islam Khan¹, Hiroaki Nabeka¹, Sheikh Mohammad Fazle Akbar², Mamun Al Mahtab³, Tetsuya Shimokawa¹, Farzana Islam¹, Seiji Matsuda¹

Affiliations

¹ Department of Anatomy and Embryology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
² Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
³ Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

No abstract available

MeSH terms

Adenosine Monophosphate / analogs & derivatives
Alanine / analogs & derivatives
Antimalarials
Antiviral Agents
COVID-19 Drug Treatment*
COVID-19* / transmission
Congenital Abnormalities*
Female
Global Health
Humans
Hydroxychloroquine
Infant, Newborn
Infant, Newborn, Diseases
Neural Tube Defects
Physicians*
Pregnancy
Pregnancy Complications, Infectious
SARS-CoV-2 / isolation & purification*

Substances

Antimalarials
Antiviral Agents
remdesivir
Adenosine Monophosphate
Hydroxychloroquine
Alanine